Stockreport

Keros Therapeutics Announces Review of Strategic Alternatives

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process LEXINGTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” [Read more]